Robert Kramer, EVP & CFO at Emergent BioSolutions Inc. (EBS), sold 3,863 shares at $24.00 ($91K) on 2014-11-07, disclosed to the SEC on 2014-11-12.
Scheduled sale ($91k) by EVP & CFO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $22.31 | 1,238 | $28K | 30.5% |
| 2 | $24.00 | 2,625 | $63K | 69.5% |
| Total | $23.46 avg | 3,863 | $91K | 100% |
| Filing → |
| EBS | SELL | 2021-01-19 | $4.0M | — | Filing → |
| EBS | SELL | 2016-04-08 | $847K | — | Filing → |
| EBS | SELL | 2016-04-05 | $3.0M | — | Filing → |